Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head-and-Neck (SCCHN)

Dirk Rades; Inga Zwaan; Tamer Soror; Christian Idel; Ralph Pries; Karl L Bruchhage; Samer G. Hakim; Nathan Y. Yu

doi:10.20944/preprints202305.1499.v1

A peer-reviewed article of this Preprint also exists.

Rades, D.; Zwaan, I.; Soror, T.; Idel, C.; Pries, R.; Bruchhage, K.L.; Hakim, S.G.; Yu, N.Y. Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN). Cancers 2023, 15, 3278. Rades, D.; Zwaan, I.; Soror, T.; Idel, C.; Pries, R.; Bruchhage, K.L.; Hakim, S.G.; Yu, N.Y. Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN). Cancers 2023, 15, 3278.

Abstract

Keywords: head-and-neck cancer; chemoradiation; cisplatin; carboplatin; loco-regional control; metastases-free survival; overall survival; toxicity.

Keywords

head-and-neck cancer; chemoradiation; cisplatin; carboplatin; loco-regional control; metasta-ses-free survival; overall survival; toxicity

Subject

Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head-and-Neck (SCCHN)

Abstract

Keywords

Subject

Comments (0)